Aladdin Healthcare Technologies SE announced have released SAAS (software as a service) based, online rapid analysis report prototype for early diagnosis for Alzheimer's Disease, based on blood test results. Ageing is a global megatrend, as the world continues to age rapidly, age-related diseases have become a significant healthcare burden for all governments. Alzheimer's Disease is one of the most crippling age-related diseases, there are more than 50 million dementia patients globally which created a global economic burden of more than $1 trillion in 2018. Currently there is no affordable and accurate early stage universal testing for Alzheimer's Disease. All methods are either invasive and painful, expensive or inaccurate. Evidence shows that early diagnosis and intervention of key diseases can not only help postpone or ameliorate symptoms but also lead to enhanced longevity. On top of this, early diagnosis is also a significant component for pharmaceutical companies to gain access to a key demographic for clinical trials that can expedite drug discovery.